Medical News |
- EP4 receptor feasible target for antithrombotic agents
- Unfavorable lipid profile associated with <i>APOE</i> isoform
- JUPITER data behind European approval released
- High intrinsic coagulation activation may increase arterial thrombosis risk
- FLAIR changes serve as clock for time since stroke onset
- Low prostate weight linked to PSMs in low-risk prostatectomy patients
- Lasofoxifene is attractive option for breast cancer prevention
- Prostate cancer becomes more aggressive with age, could impact screening
- CV benefits of fish oil may have been overestimated
- Apolipoproteins mediate Lp-PLA<sub>2</sub>–CVD link
- Eplerenone boosts survival in mild systolic heart failure patients
- HeartWare® ventricular assist system meets non-inferiority goal
- Telemedicine may reduce diabetics’ food insecurities
- HbA1C measurements misleading during iron, erythropoietin therapy
- Eplerenone boosts survival in mild systolic heart failure patients
- HeartWare® ventricular assist system meets non-inferiority goal
| EP4 receptor feasible target for antithrombotic agents Posted: 15 Nov 2010 04:00 PM PST Austrian researchers have found that human platelets express the E-type prostaglandin receptor 4, which inhibits platelet aggregation when activated. |
| Unfavorable lipid profile associated with <i>APOE</i> isoform Posted: 15 Nov 2010 04:00 PM PST Research suggests that there are close associations between APOE genotypes and lipid profiles in the Brazilian population. |
| JUPITER data behind European approval released Posted: 15 Nov 2010 04:00 PM PST Post hoc analyses of JUPITER that formed the basis for European approval of rosuvastatin have been published in the European Heart Journal. |
| High intrinsic coagulation activation may increase arterial thrombosis risk Posted: 14 Nov 2010 04:00 PM PST High levels of activated intrinsic coagulation proteins are associated with an increased risk for arterial thrombosis in young women, study findings indicate. |
| FLAIR changes serve as clock for time since stroke onset Posted: 14 Nov 2010 04:00 PM PST Signal intensity changes on fluid-attenuated inversion recovery magnetic resonance imaging provide a sensitive indicator of time since stroke onset, report researchers. |
| Low prostate weight linked to PSMs in low-risk prostatectomy patients Posted: 14 Nov 2010 04:00 PM PST Men with low-risk prostate cancer are more likely to have positive surgical margins after treatment with nerve-sparing robotic-assisted radical prostatectomy if they have a light rather than heavy prostate, researchers report. |
| Lasofoxifene is attractive option for breast cancer prevention Posted: 14 Nov 2010 04:00 PM PST The selective estrogen-receptor modulator lasofoxifene appears to reduce the risks for both total, and ER-positive invasive breast cancer in postmenopausal women with osteoporosis, the results of a randomized-controlled trial show. |
| Prostate cancer becomes more aggressive with age, could impact screening Posted: 14 Nov 2010 04:00 PM PST Study findings show that as men with prostate cancer age, more aggressive disease characteristics emerge, lessening their chances of survival compared with younger men with the disease. |
| CV benefits of fish oil may have been overestimated Posted: 14 Nov 2010 04:00 PM PST German researchers say that the benefits of omega-3 fatty acids in survivors of acute myocardial infarction, beyond those achieved with modern guideline-adjusted therapy, may have been overestimated. |
| Apolipoproteins mediate Lp-PLA<sub>2</sub>–CVD link Posted: 14 Nov 2010 04:00 PM PST Associations between circulating levels of lipoprotein-associated phospholipase A2 and cardiovascular diseases are dependent on pro-atherogenic lipid levels, research shows. |
| Eplerenone boosts survival in mild systolic heart failure patients Posted: 14 Nov 2010 04:00 PM PST Eplerenone, in addition to recommended therapy, significantly reduces cardiovascular death and hospitalization for heart failure in patients with systolic heart failure and mild symptoms, results from EMPHASIS-HF indicate. |
| HeartWare® ventricular assist system meets non-inferiority goal Posted: 14 Nov 2010 04:00 PM PST Success rates with HeartWare®, a continuous-flow left ventricular assist device for the treatment of patients with advanced heart failure, are comparable to those of commercially available devices, findings from the ADVANCE trial show. |
| Telemedicine may reduce diabetics’ food insecurities Posted: 14 Nov 2010 04:00 PM PST Low-income diabetics who live in rural areas and have concerns about sufficient food availability can still adhere to a diabetes-appropriate diet if given nutritional counseling using telemedicine, a US study suggests. |
| HbA1C measurements misleading during iron, erythropoietin therapy Posted: 14 Nov 2010 04:00 PM PST UK researchers report that glycated hemoglobin levels do not accurately reflect the glycemic control of diabetic patients who receive intravenous iron and erythropoietin-stimulating agents for co-existing chronic kidney disease. |
| Eplerenone boosts survival in mild systolic heart failure patients Posted: 14 Nov 2010 04:00 PM PST Eplerenone, in addition to recommended therapy, significantly reduces cardiovascular death and hospitalization for heart failure in patients with systolic heart failure and mild symptoms, results from EMPHASIS-HF indicate. |
| HeartWare® ventricular assist system meets non-inferiority goal Posted: 14 Nov 2010 04:00 PM PST Success rates with HeartWare®, a continuous-flow left ventricular assist device for the treatment of patients with advanced heart failure, are comparable to those of commercially available devices, findings from the ADVANCE trial show. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment